SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000812796-08-000038
Filing Date
2008-11-14
Accepted
2008-11-14 16:24:00
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 DOR 10Q 3Q - 2008 dor10q3q2008.htm 10-Q 619326
2 CERT BY CEO 10 Q 3 Q - 2008 certceo10q3q2008.htm EX-31.1 13546
3 CERT BY CFO 10 Q 3 Q - 2008 certcfo10q3q2008.htm EX-31.2 13105
4 CERT BY CEO 906 SOX 10 Q 3Q - 2008 certceo906sox10q3q2008.htm EX-32.1 7481
5 CERT BY CFO 906 SOX 10 Q 3Q - 2008 certcfo906sox10q3q2008.htm EX-32.2 7331
  Complete submission text file 0000812796-08-000038.txt   662400
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 081191730
SIC: 2834 Pharmaceutical Preparations